## Abstract A new hepatobiliary contrast agent for magnetic resonance (MR) imaging, gadolinium‐ethoxybenzy1 (EOB)‐diethylemetriaminepentaacetic acid (DTPA), was compared with Gd‐DTPA to define the potential for improving tumor‐liver contrast in a rodent liver adenocarcinoma model. With a T1‐weighte
Comparison of Gd-Bz-TTDA, Gd-EOB-DTPA, and Gd-BOPTA for dynamic MR imaging of the liver in rat models
✍ Scribed by Twei-Shiun Jaw; Shih-Hsien Chen; Yun-Ming Wang; Jui-Sheng Hsu; Yu-Ting Kuo; Yen-Yu Chiu; Kun-Bow Tsai; Tsyh-Jyi Hsieh; Gin-Chung Liu
- Book ID
- 119316944
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 970 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0257-5655
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The NMR relaxivities of GQEOB-DTPA and Gd-DTPA were determined in the kidney and liver of intact male W&tar rats immediately following sacrifice and in vitro in solutions and gels, at 1.5 T using a clinical MR scanner. Tl and T2 values of tissue samples were derived from spin-echo image sequences. T
## Purpose: To investigate the characteristics of gd-dtpa-dea as a hepatobiliary contrast agent for mr imaging in comparison with those of gd-eob-dtpa. ## Materials and methods: We undertook phantom experiments to assess t1 relaxivity for gd-dtpa-dea, gd-eob-dtpa, and gd-dtpa in human plasma. for
## Abstract ## Purpose: 1) To analyze and compare fast dynamic imaging sequences to biopsy suspect liver lesions. 2) To evaluate the additional use of hepatocyte‐specific contrast agent compared to the nonenhanced fast dynamic scans and diagnostic liver imaging. ## Materials and Methods: Image a